Literature DB >> 19146843

Validation of PON1 enzyme activity assays for longitudinal studies.

Karen Huen1, Rebecca Richter, Clement Furlong, Brenda Eskenazi, Nina Holland.   

Abstract

BACKGROUND: Paraoxonase (PON1) enzymatic activity assays are used to characterize sensitivity to organophosphates and oxidative stress. Length of sample storage, temperature and other factors may influence variability of PON1 measurements, especially in longitudinal studies.
METHODS: Effects of assay temperature, storage duration up to 7 y (-80 degrees C), freeze-thaw cycles, the type of specimen (serum or heparinized plasma) and assay variability were evaluated for 4 PON1 substrate-specific assays using samples from two pediatric cohorts and laboratory volunteers.
RESULTS: Intra- and inter-assay variation, as well as inter-laboratory variability for PON1 activities were <10%. The effect of storage duration up to 2 y was minimal. However, after 7 y, arylesterase, paraoxonase, and chlorpyrifos-oxonase activities decreased more noticeably. Similarly, while freeze-thaw cycles did not affect the PON1 activities in samples stored <2 y, this factor was more significant after 7 y for arylesterase. Assay temperature and specimen type also influenced PON1 measurements.
CONCLUSIONS: Sources of technical variability of PON1 activity assays, including storage duration, freeze-thaw, and temperature should be monitored and minimized through study design, quality control procedures and statistical methods, especially in longitudinal studies where specimens may be stored for years prior to analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19146843      PMCID: PMC2683673          DOI: 10.1016/j.cca.2008.12.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  39 in total

1.  The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192).

Authors:  Mamoru Nakanishi; Yoshikazu Takanami; Taro Maruyama; Mitsuru Murata; Yoshiko Motohashi; Satomi Nakano; Kagehiro Uchida; Chizuko Maruyama; Shingo Kyotani; Motoo Tsushima
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

2.  [Enzymatic hydrolysis of diethyl-p-nitrophenylphosphate (E 600) by human serum].

Authors:  K Krisch
Journal:  Z Klin Chem Klin Biochem       Date:  1968-01

3.  Stability of the paraoxonase phenotyping ratio in collections of human sera with differing storage times.

Authors:  M Brackley; G Carro-Ciampi; D J Stewart; J A Lowden; A K Ray; W Kalow
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1983-07

4.  The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases.

Authors:  Olga Khersonsky; Dan S Tawfik
Journal:  J Biol Chem       Date:  2006-01-10       Impact factor: 5.157

5.  Cytogenetic damage in blood lymphocytes and exfoliated epithelial cells of children with inflammatory bowel disease.

Authors:  Nina Holland; Paul Harmatz; Daniel Golden; Alan Hubbard; Yen-Ying Wu; Jin Bae; Connie Chen; Karen Huen; Melvin B Heyman
Journal:  Pediatr Res       Date:  2007-02       Impact factor: 3.756

6.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

Authors:  Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag
Journal:  J Pediatr       Date:  2005-01       Impact factor: 4.406

Review 7.  Paraoxonase 1: genetics and activities during aging.

Authors:  Francesca Marchegiani; Maurizio Marra; Fabiola Olivieri; Maurizio Cardelli; Richard W James; Massimo Boemi; Claudio Franceschi
Journal:  Rejuvenation Res       Date:  2008-02       Impact factor: 4.663

Review 8.  Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.

Authors:  Michael Aviram; Mira Rosenblat
Journal:  Free Radic Biol Med       Date:  2004-11-01       Impact factor: 7.376

9.  PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity.

Authors:  Clement E Furlong; Nina Holland; Rebecca J Richter; Asa Bradman; Alan Ho; Brenda Eskenazi
Journal:  Pharmacogenet Genomics       Date:  2006-03       Impact factor: 2.089

10.  Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns.

Authors:  Nina Holland; Clement Furlong; Maria Bastaki; Rebecca Richter; Asa Bradman; Karen Huen; Kenneth Beckman; Brenda Eskenazi
Journal:  Environ Health Perspect       Date:  2006-07       Impact factor: 9.031

View more
  30 in total

Review 1.  Paraoxonase-1 and Early-Life Environmental Exposures.

Authors:  Judit Marsillach; Lucio G Costa; Clement E Furlong
Journal:  Ann Glob Health       Date:  2016 Jan-Feb       Impact factor: 2.462

2.  R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.

Authors:  Abdolkarim Mahrooz; Ghorban Gohari; Mohammad-Bagher Hashemi; Mehryar Zargari; Hadis Musavi; Mahmoud Abedini; Ahad Alizadeh
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

3.  Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population.

Authors:  Yi Han; Rajkumar Dorajoo; Tingjing Ke; Burger Ayala; Xuling Chang; Chiea-Chuen Khor; Rob M van Dam; Jian-Min Yuan; Woon-Puay Koh; Jianjun Liu; Daniel Y T Goh; Yechiel Friedlander; Chew-Kiat Heng
Journal:  Atherosclerosis       Date:  2015-02-25       Impact factor: 5.162

4.  Association between rs662 (A > G) and rs854560 (A > T) polymorphisms in PON1 gene and the susceptibility for psoriasis in mestizo population of Western Mexico.

Authors:  A A Hernández-Collazo; Oscar Pérez-Méndez; Victoria López-Olmos; V Delgado-Rizo; J F Muñoz-Valle; Erika Martínez-López; D G Villanueva-Quintero; Carolina Domínguez-Díaz; Mary Fafutis-Morris; Anabell Alvarado-Navarro
Journal:  Mol Biol Rep       Date:  2020-12-07       Impact factor: 2.316

5.  Organophosphate pesticide levels in blood and urine of women and newborns living in an agricultural community.

Authors:  Karen Huen; Asa Bradman; Kim Harley; Paul Yousefi; Dana Boyd Barr; Brenda Eskenazi; Nina Holland
Journal:  Environ Res       Date:  2012-06-08       Impact factor: 6.498

6.  Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children.

Authors:  Karen Huen; Lisa Barcellos; Kenneth Beckman; Sherri Rose; Brenda Eskenazi; Nina Holland
Journal:  Environ Mol Mutagen       Date:  2011-03       Impact factor: 3.216

Review 7.  The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.

Authors:  Toby B Cole; Karen Jansen; Sarah Park; Wan-Fen Li; Clement E Furlong; Lucio G Costa
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

8.  PON1 DNA methylation and neurobehavior in Mexican-American children with prenatal organophosphate exposure.

Authors:  Karen Huen; Olivia Solomon; Katherine Kogut; Brenda Eskenazi; Nina Holland
Journal:  Environ Int       Date:  2018-08-30       Impact factor: 9.621

9.  Organophosphate pesticide exposure, PON1, and neurodevelopment in school-age children from the CHAMACOS study.

Authors:  Brenda Eskenazi; Katherine Kogut; Karen Huen; Kim G Harley; Maryse Bouchard; Asa Bradman; Dana Boyd-Barr; Caroline Johnson; Nina Holland
Journal:  Environ Res       Date:  2014-08-27       Impact factor: 6.498

10.  Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms.

Authors:  Karen Huen; Kim Harley; Jordan Brooks; Alan Hubbard; Asa Bradman; Brenda Eskenazi; Nina Holland
Journal:  Environ Health Perspect       Date:  2009-06-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.